T. Kauppila et al., AN ATTEMPT TO ATTENUATE EXPERIMENTAL PAIN IN HUMANS BY DEXTROMETHORPHAN, AN NMDA RECEPTOR ANTAGONIST, Pharmacology, biochemistry and behavior, 52(3), 1995, pp. 641-644
Dextromethorphan (100 mg, orally), an NMDA receptor antagonist, did no
t significantly attenuate pain intensity or unpleasantness induced by
experimental ischemia or by topical capsaicin in healthy human subject
s, nor did it increase the threshold for heat pain or mechanical pain.
A dose of 200 mg produced marked side effects. Thus, systemically adm
inistered dextromethorphan does not attenuate pain at clinically appli
cable doses in humans.